Format

Send to

Choose Destination
Allergol Int. 2017 Apr;66(2):190-204. doi: 10.1016/j.alit.2016.11.003. Epub 2017 Jan 18.

Japanese guidelines for childhood asthma 2017.

Author information

1
Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan. Electronic address: harakawa@gunma-u.ac.jp.
2
Karatsu Medical and Welfare Center for People with Disabilities, Saga, Japan.
3
Chiba Rosai Hospital, Chiba, Japan.
4
Department of Allergy, Clinical Research Center for Allergology and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Kanagawa, Japan.
5
Heisei College of Health Sciences, Gifu, Japan; Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
6
National Hospital Organization, Fukuoka National Hospital, Fukuoka, Japan.
7
National Hospital Organization, Shimoshizu National Hospital, Chiba, Japan.
8
Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan; Kita Kanto Allergy Institute, Gunma, Japan.

Abstract

The Japanese Guideline for the Diagnosis and Treatment of Allergic Diseases 2017 (JAGL 2017) includes a minor revision of the Japanese Pediatric Guideline for the Treatment and Management of Asthma 2012 (JPGL 2012) by the Japanese Society of Pediatric Allergy and Clinical Immunology. The section on child asthma in JAGL 2017 provides information on how to diagnose asthma between infancy and adolescence (0-15 years of age). It makes recommendations for best practices in the management of childhood asthma, including management of acute exacerbations and non-pharmacological and pharmacological management. This guideline will be of interest to non-specialist physicians involved in the care of children with asthma. JAGL differs from the Global Initiative for Asthma Guideline in that JAGL emphasizes diagnosis and early intervention of children with asthma at <2 years or 2-5 years of age. The first choice of treatment depends on the severity and frequency of symptoms. Pharmacological management, including step-up or step-down of drugs used for long-term management based on the status of asthma control levels, is easy to understand; thus, this guideline is suitable for the routine medical care of children with asthma. JAGL also recommends using a control test in children, so that the physician aims for complete control by avoiding exacerbating factors and appropriately using anti-inflammatory drugs (for example, inhaled corticosteroids and leukotriene receptor antagonists).

KEYWORDS:

Acute exacerbation; Anti-inflammatory drugs; Childhood asthma; Guideline; Long-term management

PMID:
28108245
DOI:
10.1016/j.alit.2016.11.003
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center